Beijing Balance Medical Technology Co Ltd (688198.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100005X15

Price
73.70 CNY
Market cap
10.15 bn CNY
P/E (2025)
52.45
P/S (2025)
16.37
Dividend yield
1.09 %
Net margin
31.21 %
Return on equity (ROE)
14.59 %
Return on assets (ROA)
11.93 %

Beijing Balance Medical Technology Co Ltd financials

Fiscal year20242025
Revenue501.88 m CNY620.15 m CNY
Gross profit443.35 m CNY553.06 m CNY
Operating income138.12 m CNY205.80 m CNY
EBIT151.25 m CNY207.57 m CNY
Net income146.33 m CNY193.57 m CNY
Diluted EPS – continuing operations1.07 CNY1.41 CNY

Full history since 2016, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Beijing Balance Medical Technology Co Ltd

Beijing Balance Medical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of artificial bioprosthetic valve medical devices in China and internationally. It offers bovine pericardial, porcine aortic tissue, and limiting expandable artificial biological heart valves, as well as tricuspid annuloplasty ring for heart valve repair and treatment. The company also provides outflow tract single valve patch, pulmonary valved conduit, cardiothoracic biopatch, thoracic surgery biological patch, and dacron patch, as well as ventricular septal defect occluder, PDA occluder, ASD occluder, and cardiovascular occluder delivery system for congenital heart disease treatment. In addition, it offers neurosurgery microvascular pressure relief gasket, neurosurgical biopatch, and biological hernia patch for soft tissue repair. The company was founded in 2001 and is headquartered in Beijing, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.